MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Transcranial Direct Current Stimulation for Freezing of Gait in Parkinson’s Disease

    C-H. Tsai, H-C. Huang, M-K. Lu, J-R. Duann, S-T. Tsai, B-L. Liu (Taichung, Taiwan)

    Objective: To investigate the impact of anodal transcranial direct current stimulation (tDCS) on freezing of gait (FOG) among individuals diagnosed with Parkinson’s disease (PD). Background:…
  • 2024 International Congress

    V-ATPase subunit V1G1 overexpression conferred the mice neuroprotection during MPTP exposure

    YIM. Wang, Y. Li, Y. Xia, L. Kou, T. Wang (武汉市, China)

    Objective: Elucidating the role of lysosomal dysfunction due to altered stability and expression levels of V-type proton ATPase subunit G (V1G1) in the degradation and…
  • 2024 International Congress

    Sexual Dimorphism in Clinical Subtypes, Biomarkers and Disease Progression of Parkinson’s Disease

    SM. Fereshtehnejad, H. Azizi, J. Lökk, Y. Zeighami (Toronto, Canada)

    Objective: To investigate differences in clinical subtypes, biomarkers, and course of progression in Parkinson’s disease (PD) between the two biological sexes. Background: PD is a…
  • 2024 International Congress

    Comprehensive Strategy for Increasing Clinical Research Participation of Black and Hispanic Patients with Parkinsonism

    D. Quintana Mora, Y. Mendez, A. Cervera, J. Crary, R. Walker, M. Nirenberg (New York, USA)

    Objective: To implement and test a multidimensional strategy for increasing racial and ethnic diversity in parkinsonism research. Background: Diversity in research participation is critical for…
  • 2024 International Congress

    What you should know about your patient.

    V. Mcconvey (Elwood, Australia)

    Objective: Support understanding of concerns of the Lesbian, Gay, Bisexual, Transgender Intersex, Queer +(LGBTIQ+) community and how they impact on health professional  interactions Background: 9-10%…
  • 2024 International Congress

    Scoping Review of Caregiver Burden in Parkinson’s Disease

    S. Luehrsen, I. Pretzer-Aboff, R. Brown (Richmond, USA)

    Objective: To evaluate caregiver burden and stress in Parkinson’s disease and factors that may influence different burden and stress levels. Background: N/A Method: A systematic…
  • 2024 International Congress

    Ethnic Diversity and Symptomatology in Parkinson’s Disease with a Focus on Falls and Vertical Gaze Palsy

    D. Trivedi, C. Edwards, KC. Dey, E. Camboe, T. Haque, A. Joseph, J. Kahan, D. Gallagher, T. Boyle, C. Budu, B. Huxford, C. Simonet, S. Ganesh, A. Lee, C. Marshall, A. Noyce, A. Zirra (London, United Kingdom)

    Objective: The objective of this study was to explore atypical features in the clinical phenotype of people with Parkinson’s disease (PwP) enrolled in the East…
  • 2024 International Congress

    Passive smartphone speech monitoring in isolated rapid eye movement sleep behaviour disorder

    V. Illner, M. Novotny, T. Kouba, T. Tykalova, M. Simek, P. Sovka, J. Svihlik, E. Ruzicka, K. Sonka, P. Dusek, J. Rusz (Prague 6, Czech Republic)

    Objective: We aimed to design and test the sensitivity of a fully-automated and noise-resistant smartphone-based system that can unobtrusively screen for prodromal parkinsonian speech disorder…
  • 2024 International Congress

    Focused Ultrasound Therapy Treatment for Parkinson’s Disease

    Z. Muttalib, B. Syed, M. Alam, D. Nadora, U. Ansari, R. Sedighi, A. Vemulapalli, S. Asad (Elk Grove, USA)

    Objective: Parkinson’s Disease is a neurodegenerative disease that mainly affects the substantia nigra and nigrostriatal pathway and leads to rigidity, loss of muscle tone, tremors,…
  • 2024 International Congress

    Exploring Retrospectively the Predisposing Factors of Sleep Disorders in Parkinson’s Disease.

    SF. Arechavala Lopez, I. Fuentes Calvo, AJ. Hernández-Medrano, A. Cervantes-Arriaga, M. Rodríguez-Violante (CDMX, Mexico)

    Objective: Identify the predisposing or exacerbating factors of sleep disorders in Parkinson's disease, and examine their association with levodopa treatment. Background: Parkinson's disease (PD) is…
  • « Previous Page
  • 1
  • …
  • 158
  • 159
  • 160
  • 161
  • 162
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley